Company Overview

Update
Founded:
2007
Founders:
Gudmundur F. Sigurjonsson, Baldur Tumi Baldursson, Hilmar Kjartansson (M.D.), See All (4)
Headquarters:
Ísafjörður
Funding:
$4M
Categories:
Biotechnology

Kerecis is a developer of patent-pending MariGen™, an omega3 fish-skin acellular dermal matrix transplantation technology.

Description

Update

Kerecis is developing the MariGen™ Omega3 acellular dermal matrix technology for use in products to treat chronic wounds, for hernia repair, breast reconstruction and abdominal wall reconstruction. Our patent pending acellular fish skin derived material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.

Current Team (6)

Update

Funding Rounds (4) - $4M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    Eyrargata 2

    400 Isafjordur

    Ísafjörður,

    ISL

Competitors (1)

Update